TrialBritish journal of cancer2000

Survival in renal cell carcinoma: a randomized evaluation of tamoxifen vs interleukin-2, alpha-interferon (leucocyte) and tamoxifen.

E Huland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.